Loading... Please wait... Loading... Please wait...
ESTIMATED
04/25/2024
04/25/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 4 | -$4.41 | -$4.41 | -$4.41 |
| Q2 2024 | 14 | $1.53 | $1.81 | $1.68 |
| Q3 2024 | 9 | $1.64 | $1.64 | $1.64 |
| Q4 2024 | 6 | $1.68 | $1.68 | $1.68 |
| Q1 2025 | 7 | $1.83 | $1.83 | $1.83 |
| Q2 2025 | 8 | $1.85 | $1.85 | $1.85 |
| Q3 2025 | 7 | $1.85 | $1.85 | $1.85 |
| Q4 2025 | 7 | $1.79 | $1.79 | $1.79 |
| Q1 2026 | 6 | $1.52 | $1.52 | $1.52 |
| Q2 2026 | 11 | $1.94 | $1.94 | $1.94 |
| Q3 2026 | 6 | $1.93 | $1.93 | $1.93 |
| Q4 2026 | 9 | $1.85 | $1.85 | $1.85 |
Bristol-Myers Squibb Company last posted its earnings results on Thursday, April 25th, 2024. The company reported $-4.4 earnings per share for the quarter, topping analysts' consensus estimates of $-4.41 by $0.0099999999999998. The company had revenue of 11.87 B for the quarter and had revenue of 45.01 B for the year. Bristol-Myers Squibb Company has generated $4 earnings per share over the last year ($3.86 diluted earnings per share) and currently has a price-to-earnings ratio of -13.67. Bristol-Myers Squibb Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 26th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 04/25/2024 | Q1 2024 | -$4.41 | -$5.89 | -1.48 | $11.48 B | $11.87 B | 02/13/2024 | Q4 2023 | $0.87 | $11.19 B | $11.48 B | 10/26/2023 | Q3 2023 | $1.76 | $0.94 | -0.82 | $10.97 B | 07/27/2023 | Q2 2023 | $1.99 | $0.99 | -1 | $11.23 B | 04/27/2023 | Q1 2023 | $1.98 | $1.08 | -0.9 | $11.50 B | $11.34 B | 02/14/2023 | Q4 2022 | $0.96 | $11.19 B | $11.41 B | 10/26/2022 | Q3 2022 | $0.75 | $11.22 B | 07/27/2022 | Q2 2022 | $1.79 | $0.67 | -1.12 | $11.89 B | 04/29/2022 | Q1 2022 | $1.92 | $0.60 | -1.32 | $11.65 B | 02/09/2022 | Q4 2021 | $1.10 | $12.04 B | $11.99 B | 10/27/2021 | Q3 2021 | $1.91 | $0.70 | -1.21 | $11.61 B | $11.62 B | 07/28/2021 | Q2 2021 | $1.88 | $0.47 | -1.41 | $11.27 B | $11.70 B | 04/29/2021 | Q1 2021 | $1.80 | $0.90 | -0.9 | $11.07 B | 02/10/2021 | Q4 2020 | -$4.45 | $10.73 B | $11.07 B | 11/05/2020 | Q3 2020 | $1.49 | $0.83 | -0.66 | $10.32 B | $10.54 B | 08/06/2020 | Q2 2020 | $1.46 | -$0.04 | -1.5 | $9.99 B | $10.13 B | 05/07/2020 | Q1 2020 | $1.48 | -$0.34 | -1.82 | $10.78 B | 02/24/2020 | Q4 2019 | -$0.55 | $7.12 B | $7.95 B | 10/31/2019 | Q3 2019 | $1.06 | $0.83 | -0.23 | $5.90 B | $6.01 B | 07/25/2019 | Q2 2019 | $1.06 | $0.88 | -0.18 | $6.11 B | $6.27 B |
|---|
A. Bristol-Myers Squibb Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 26th, 2024 based off last year's report dates.
A. In the previous quarter, Bristol-Myers Squibb Company (NYSE:BMY) reported $-4.4 earnings per share (EPS) to beat the analysts' consensus estimate of $-4.41 by $0.0099999999999998.
A. The conference call for Bristol-Myers Squibb Company's latest earnings report can be listened to online.
A. The conference call transcript for Bristol-Myers Squibb Company's latest earnings report can be read online.
A. Bristol-Myers Squibb Company (NYSE:BMY) has a recorded annual revenue of $45.01 B.
A. Bristol-Myers Squibb Company (NYSE:BMY) has a recorded net income of $45.01 B. Bristol-Myers Squibb Company has generated $3.88 earnings per share over the last four quarters.
A. Bristol-Myers Squibb Company (NYSE:BMY) has a price-to-earnings ratio of -13.67 and price/earnings-to-growth ratio is -1.61.
